DJIA 18,024.06 183.54 1.03%
NASDAQ 5,005.39 63.97 1.29%
S&P 500 2,108.29 22.78 1.09%
market minute promo

Amarin Corp plc (ADR) (NASDAQ: AMRN)

1.89 -0.03 (-1.56%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMRN $1.89 -1.56%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.95
Previous Close $1.92
Daily Range $1.86 - $2.00
52-Week Range $0.78 - $3.33
Market Cap $334.7M
P/E Ratio -5.33
Dividend (Yield) $0.00 (0.0%)
Volume 2,202,636
Average Daily Volume 2,933,325
Current FY EPS -$0.40




Drug Makers

Amarin Corp plc (ADR) (AMRN) Description

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders. Website:

News & Commentary Rss Feed

In Case You Missed It, This New Study Suggests America Is a Nation of Couch Potatoes

Put plainly, we as a nation are becoming increasing sedentary. Don't believe me? Take a look at the findings of this latest report from the Physical Activity Council.

Amarin May Struggle Some More Amid Biotech Selloff

European ADRs Contract as Tech Stock Losses Weigh

Why Amarin Corp Plc Slumped Today

Amarin Corp Plc's shares fell after it received a complete response letter from the FDA.

European ADRs Trading Lower Despite Mining Gains

More Awareness Of Amarin's Vascepa And Its Unique Cardiovascular Benefits Is Needed

Amarin: Vascepa Growth Moderates, But Long-Term Liquidity Still Appears Fine

With Shares Down But Prescriptions Up, It's Time To Accumulate Amarin

Benzinga's Top #PreMarket Losers

Amarin's Constellation Of Possibilities Defy The Fall Of Night

See More AMRN News...

AMRN's Top Competitors

AMRN $1.89 (-1.56%)
Current stock: AMRN
JNJ $100.13 (0.94%)
Current stock: JNJ
NVS $103.35 (1.52%)
Current stock: NVS
RHHBY $36.04 (0.45%)
Current stock: RHHBY